Effect and Safety of dose-escalating treatment of Imidafenacin for Overactive Bladder : CLSS-modified-Self-Assessment Goal Achievement questionnaire
Phase of Trial: Phase III
Latest Information Update: 13 May 2016
At a glance
- Drugs Imidafenacin (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- Acronyms CLSS-modified-SAGA
- 27 Jan 2014 Status changed from active, no longer recruiting to completed as reported by the University Hospital Medical Information Network, Japan record.
- 23 Jan 2013 Planned End Date changed from 1 Mar 2012 to 31 Mar 2013 as reported by University Hospital Medical Information Network - Japan.
- 23 Jan 2013 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.